Histopathology of aortic complications in bicuspid aortic valve versus Marfan syndrome: relevance for therapy?

Identification of fibrillin 1 gene mutations in patients with bicuspid aortic valve (BAV) without Marfan syndrome

(2014) Guglielmina Pepe et al.   BMC Medical Genetics

Bicuspid aortic valve: phosphorylation of c-Kit and downstream targets are prognostic for future aortopathy

(2014) Nimrat Grewal et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Ascending aorta dilation in association with bicuspid aortic valve: A maturation defect of the aortic wall

(2014) Nimrat Grewal et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Normal and abnormal development of the aortic wall and valve: correlation with clinical entities

(2014) N. Grewal et al.   Netherlands Heart Journal

The Effect of Angiotensin-converting Enzyme Inhibitors on the Rate of Ascending Aorta Dilation in Patients with Bicuspid Aortic Valve

(2014) Daniella Ohnemus et al.   Congenital Heart Disease

Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial

(2013) M. Groenink et al.   EUROPEAN HEART JOURNAL

Aortic dilatation patterns and rates in adults with bicuspid aortic valves: a comparative study with Marfan syndrome and degenerative aortopathy

(2013) Delphine Detaint et al.   HEART

Losartan Added to β-Blockade Therapy for Aortic Root Dilation in Marfan Syndrome: A Randomized, Open-Label Pilot Study

(2013) Hsin-Hui Chiu et al.   MAYO CLINIC PROCEEDINGS

Association of Marfan syndrome and bicuspid aortic valve: Frequency and outcome

(2012) Stefano Nistri et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The Ghent Marfan Trial — A randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers

(2011) Katarina Möberg et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Incidence of Aortic Complications in Patients With Bicuspid Aortic Valves

(2011) Hector I. Michelena et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Differential Temporal and Spatial Progerin Expression during Closure of the Ductus Arteriosus in Neonates

(2011) Regina Bökenkamp et al.   PLoS One

Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome

(2010) Delphine Detaint et al.   Archives of Cardiovascular Diseases

2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary

(2010) Loren F. Hiratzka et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations

(2010) Fabiana I Gambarin et al.   Journal of Cardiovascular Medicine

The revised Ghent nosology for the Marfan syndrome

(2010) B. L. Loeys et al.   JOURNAL OF MEDICAL GENETICS

Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial

(2010) Teodora Radonic et al.   Trials

Outcomes in Adults With Bicuspid Aortic Valves

(2008) Nikolaos Tzemos   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Angiotensin II Blockade and Aortic-Root Dilation in Marfan's Syndrome

(2008) Benjamin S. Brooke et al.   NEW ENGLAND JOURNAL OF MEDICINE

Variation in the histopathological features of patients with ascending aortic aneurysms: a study of 111 surgically excised cases

(2007) M J Collins et al.   JOURNAL OF CLINICAL PATHOLOGY